Accelerating drug development to FTIH: Potential of new expression technologies

Size: px
Start display at page:

Download "Accelerating drug development to FTIH: Potential of new expression technologies"

Transcription

1 Accelerating drug development to FTIH: Potential of new expression technologies Lekan Daramola Associate Director Biopharmaceutical Development, Cell Culture & Fermentation Sciences CMC Strategy Forum Europe 2014

2 Outline Introduction Potential strategies to accelerate FTIH Can we use Transient expression platform? Pros and Cons MedImmune s proprietary CHO transient system Conclusion 2

3 Introduction Conventional method for producing biologics for IND is based on stable cell line expression platforms Cell line development is typically time consuming (6-12 months) and resource intensive Impact on accelerating drug candidates to IND Clonal stable cell lines used to produce biologic for IND for ~20 years despite significant improvements in other protein expression technologies 3

4 Stable Cell Line Based Drug Development Typical Critical Path Gene optimisation, Vector construction Transfection Extensive Screening, Bulk up Parental Cell lines Extensive Screening, Bulk up Clonal Cell lines Cell Banking 8 6 Cell bank Characterisation Phenotypic Characterisation Genetic Characterisation Product Quality Clone 1 Clone 2 Clone Clone 3 4 Choose Manufacturing cell line Bioreactor process development, Scale up Cell Bank Safety testing GMP Production CLD timeline range from 6 12 months 4

5 Potential strategies to shorten drug development timelines Synthon Non-Clonal transfected Cell lines (Parental) Stable pools (transfected cells) Plant protein expression Microbial expression Cell-free protein expression Protein Sciences - Baculovirus expression Transient expression 5

6 Transient vs. Stable Expression Systems DNA plasmid STABLE Transfection TRANSIENT Nucleus Nucleus Genomic Plasmids Integrated Plasmid Genomic Transgene DNA integrated into host genome Transfect in many copies of plasmid Expression stably maintained over many months Expression over a few days/weeks Transgene DNA passed to progeny Transcription without integration into host genome Gram-amounts but time-consuming Recombinant cell lines can be stored frozen Repeat transfection for repeat protein batches Rapid for µg to gram amounts 6

7 Why consider Transient system now? Low expression level no longer an issue Higher titres up to 2g/L reported Successful use of robust, industry standard cell line for transient expression CHO cell line Same cell host as stable cell line can now be used for Transient expression Production process transferable from stable to transient Scalable process 7

8 Expression Strategy Target Evaluation Target validation Preproject Lead Isolation Lead Optimisation Lead Profiling Pre-clinical Development Clinical Development Transient Transient gene gene expression small potential amounts >gram amounts CHO pool > gram CHO Stable cell line multi gram amounts Can Transient expression be used for GMP production?

9 Transient Expression Production Process: What it could look like? DNA GMP/non- GMP grade Cell Bulk up Transfection (Chemical or Electroporation) Grams Kg of protein Day1 Cells qualified host cell bank Transfection Production Harvest Fully characterised cells and transfected with high quality DNA Scaled up according to drug requirements Up to Day20 9

10 Benefits: Transient Material and FTIH Speed Potentially the fastest route to FTIH No cell line development required DNA purification and production phase Increase in throughput Potential increase in capacity as CLD is no longer on critical path? Organisational Reduced Cost Projects with increase rate of attrition speed Postpone resource intensive CLD to later clinical stages Potentially more cost effective to FTIH 10

11 Other Benefits of Using Transient Material Only one cell bank is required transient host cell line Same host cell line transfected with different DNA Only the host cell will require safety and genetic characterisation Wealth of information and experience from cell, gene therapy and vaccine production e.g. GMP DNA production, DNA stability, transfections Ideal for personalised medicine, low dose indications, orphan drugs Personalise d Medicine 11

12 Concerns Low expression in transient systems Process requirements: different to stable lines? Process consistency, robustness, Comparability risks Comparability with stable cell lines - later clinical stages Process development upstream and downstream Scalability Process contaminants Transfection reagent 12

13 Precedence Vaccine Production using transient transfection of HEK293 cells for clinical studies NIH FDA approved VLP production (influenza) for Phase 1 studies Working on scale up for commercial production Flu vaccine commercial production using baculovirus vector and insect cells - transient expression approach FluBlok the first FDA approved recombinant trivalent hemagglutinin vaccine. Cell/Gene therapy viral transduction, electroporation 13

14 MedImmune Proprietary CHO Transient System MedImmune has developed an industry leading proprietary CHO transient expression system Highest titres reported/published in the industry (2g/L IgG) Scalable, easy to use transfection process Successfully used to express several IgGs and non-iggs for preclinical studies over many years Improved productivity over the years as a result of continuous process development effort 14

15 Transfection Process Simple, scalable transfection protocol No media exchange required pre or post transfection High yielding process, highest to-date 2g/L of IgG i.e. potentially up to 40g crude from a 20L transfection culture Examples of >1g/L IgG titre from CHO transient platform Successfully used to fast-track research grade material production for numerous projects over the past 7 years Scaled up to 250L 15

16 Product Quality Robust process will produce consistent product quality Literature and in-house data suggest IgG product quality is comparable to material from stable cell lines Glycan data suggest transient material is comparable with stable cell line material. Within the micro-heterogeneity expected in stables e.g clone to clone micro-heterogeneity. 16

17 Conclusion Conventional stable cell generation can be time consuming Alternative expression strategies exist to accelerate timelines to FTIH Pools Cell-free expression system Different expression platforms Propose that an high yielding scalable CHO transient system is a potential viable option to accelerate timelines to FTIH Already in use for viral vaccine production e.g. viral recombinant protein, Virus-Like Particles Pros and Cons Use of Transient expression for manufacturing is now technically feasible Increase awareness 17

18 Acknowledgements Early Expression and Supply Cell Culture and Fermentation Sciences (CCFS) Group, MedImmune Ray Field Paul Varley 18

Eden Biodesign ebook Monoclonal Antibody Production: Building the Platform

Eden Biodesign ebook Monoclonal Antibody Production: Building the Platform Eden Biodesign ebook Monoclonal Antibody Production: Building the Platform CHAPTER 1: Overview CHAPTER 2: Challenges CHAPTER 3: Purification Methodology CHAPTER 4: Results CHAPTER 5: About Eden Biodesign

More information

Cell Line: HD-BIOP3 Suspension adapted GS null CHO K1 cells

Cell Line: HD-BIOP3 Suspension adapted GS null CHO K1 cells Cell Line Data Pack Cell Line: HD-BIOP3 Suspension adapted GS null CHO K1 cells t + 44 ()1223 65558 f + 44 ()1223 655581 e info@horizondiscovery.com w www.horizondiscovery.com Horizon Discovery, 71 Cambridge

More information

Mammalian Cell Culture: Current Status, Future Prospects

Mammalian Cell Culture: Current Status, Future Prospects Cell Culture and Upstream Processing, Berlin, September 2004 Mammalian Cell Culture: Current Status, Future Prospects John Birch Lonza Cell Culture: an Industrial Process Much of the early process development

More information

LFB GROUP & SANOFI combine their bioproduction capabilities to provide integrated CMO services for biopharmaceuticals

LFB GROUP & SANOFI combine their bioproduction capabilities to provide integrated CMO services for biopharmaceuticals LFB GROUP & SANOFI combine their bioproduction capabilities to provide integrated CMO services for biopharmaceuticals MAbLaunch TM is a joint bioproduction platform combining LFB Biomanufacturing (LFB

More information

Advances in The Development of Biopharmaceuticals

Advances in The Development of Biopharmaceuticals Advances in The Development of Biopharmaceuticals The application of modern technologies and services to the development of Biopharmaceutical processes Dr Jonathan H Dempsey Process Science Fellow Invitrogen

More information

Optimization of Cell Culture Processes for the Production of Therapeutic Monoclonal Antibodies. John Birch

Optimization of Cell Culture Processes for the Production of Therapeutic Monoclonal Antibodies. John Birch Optimization of Cell Culture Processes for the Production of Therapeutic Monoclonal Antibodies John Birch Facilities U.K. R &D + small scale manufacture 200 litre airlift reactors 2000 litre airlift reactors

More information

Luca Romagnoli, Ph.D. Business Development Manager

Luca Romagnoli, Ph.D. Business Development Manager Modelli innovativi di produzione per lo sviluppo di un processo altamente qualitativo di farmaci biologici Luca Romagnoli, Ph.D. Business Development Manager BIOLOGICAL DRUGS - SOURCES Monoclonal antibodies

More information

LFB GROUP & SANOFI combine their bioproduction capabilities to provide integrated CMO services for biopharmaceuticals

LFB GROUP & SANOFI combine their bioproduction capabilities to provide integrated CMO services for biopharmaceuticals LFB GROUP & SANOFI combine their bioproduction capabilities to provide integrated CMO services for biopharmaceuticals MAbLaunch TM is a joint bioproduction platform combining LFB Biomanufacturing (LFB

More information

Valentina Gualato, Ph.D. Process Development Scientist

Valentina Gualato, Ph.D. Process Development Scientist COMPANY PRESENTATION Quality and Innovation Valentina Gualato, Ph.D. Process Development Scientist MISSION areta international is a biotech company dedicated to the contract development and manufacturing

More information

Improving GS-CHO Cell Line Selection: Reducing Time to Clinic

Improving GS-CHO Cell Line Selection: Reducing Time to Clinic Cell Line Development and Engineering 2-6 March 2009, Berlin Improving GS-CHO Cell Line Selection: Reducing Time to Clinic Adrian Haines, 2009 Lonza Biologics plc, Slough, UK Disclaimer Certain matters

More information

From Research Services and Process Development to GMP Manufacturing

From Research Services and Process Development to GMP Manufacturing From Research Services and Process Development to GMP Manufacturing P a r ag o n B i o s e r v i c e s, I n c. A contract research and GMP manufacturing organization (CMO) with a focus on the development

More information

ATGCell. ATGCell Inc.

ATGCell. ATGCell Inc. ATGCell Inc. http://www.atgcell.com Corporate ATGCell is a revenue generating spin-off biotech company from University of Alberta. Incorporated in September 2007; 6 employees (5 PhD and 1 MSc); several

More information

ESTABLISHMENT OF CELL LINES FOR MANUFACTURING RECOMBINANT ANTIBODIES. Dr Andrew Racher

ESTABLISHMENT OF CELL LINES FOR MANUFACTURING RECOMBINANT ANTIBODIES. Dr Andrew Racher ESTABLISHMENT OF CELL LINES FOR MANUFACTURING RECOMBINANT ANTIBODIES Dr Andrew Racher Lonza Biologics plc, 2004 Structure of talk Issues Selection of a high producing cell line Selection for process compatibility

More information

PlantForm Corporation

PlantForm Corporation PlantForm Corporation Professor J. Christopher Hall CSO PlantForm Corporation Canada s Top10 Winner Life Sciences 2008/9 Innovator of the Year Guelph, Canada, 2010 Opportunity The introduction of more

More information

Manufacturing process of biologics

Manufacturing process of biologics Manufacturing process of biologics K. Ho Afssaps, France 2011 ICH International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use 2011 ICH 1 Disclaimer:

More information

Selection of Cell Lines for Manufacturing Therapeutic Antibodies by Flow Cytometric Cell Sorting. Andrew Racher Lonza Biologics

Selection of Cell Lines for Manufacturing Therapeutic Antibodies by Flow Cytometric Cell Sorting. Andrew Racher Lonza Biologics Selection of Cell Lines for Manufacturing Therapeutic Antibodies by Flow Cytometric Cell Sorting Andrew Racher Lonza Biologics Structure of Talk 1. The Problem 2. Possible Solutions 3. Solution Chosen

More information

The Importance of Developing a High Yield of Product

The Importance of Developing a High Yield of Product European Antibody Congress Lyon, 3 rd November 2005 The Importance of Developing a High Yield of Product John Birch, Lonza Biologics plc Monoclonal Antibodies A Success Story Fastest growing segment of

More information

Accelerating Antibody Process Development: Exploring the Synergies Between Engineered Host Cells and Process Development

Accelerating Antibody Process Development: Exploring the Synergies Between Engineered Host Cells and Process Development Pharma&Biotech Accelerating Antibody Process Development: Exploring the Synergies Between Engineered Host Cells and Process Development James Rance PhD Head of Development Services Singapore Lonza Biologics

More information

Exciting Trends in Bioprocessing

Exciting Trends in Bioprocessing Exciting Trends in Bioprocessing Alfred Doig and Susan Dana Jones, Ph.D. April 20, 2015 BioProcess Technology Consultants, Inc. 12 Gill Street, Suite 5450 Woburn, MA 01801 Exciting Trends in Bioprocessing

More information

Recombinant protein vaccines produced in insect cells

Recombinant protein vaccines produced in insect cells Recombinant protein vaccines produced in insect cells Manon M.J. Cox Hong Kong 25JAN2013 Flublok BREAKING NEWS 16JAN2013 FDA approves Flublok for the prevention of influenza in adults 18-49 years old The

More information

Transfection-Transfer of non-viral genetic material into eukaryotic cells. Infection/ Transduction- Transfer of viral genetic material into cells.

Transfection-Transfer of non-viral genetic material into eukaryotic cells. Infection/ Transduction- Transfer of viral genetic material into cells. Transfection Key words: Transient transfection, Stable transfection, transfection methods, vector, plasmid, origin of replication, reporter gene/ protein, cloning site, promoter and enhancer, signal peptide,

More information

Integrated Protein Services

Integrated Protein Services Integrated Protein Services Custom protein expression & purification Version DC04-0012 Expression strategy The first step in the recombinant protein generation process is to design an appropriate expression

More information

Mab manufacturing today and tomorrow. Reducing risk, reducing cost. Reducing costs, informing decisions, insight for innovation.

Mab manufacturing today and tomorrow. Reducing risk, reducing cost. Reducing costs, informing decisions, insight for innovation. Mab manufacturing today and tomorrow. Reducing risk, reducing cost. Reducing costs, informing decisions, insight for innovation. Summary Monoclonal antibodies are expensive to develop and to manufacture.

More information

Vaccine Manufacturing Facilities of the Future. Howard L. Levine, Ph.D. Vaccines Europe London, England December 1 2, 2010

Vaccine Manufacturing Facilities of the Future. Howard L. Levine, Ph.D. Vaccines Europe London, England December 1 2, 2010 Vaccine Manufacturing Facilities of the Future Howard L. Levine, Ph.D. Vaccines Europe London, England December 1 2, 2010 Challenges in the Production of Vaccines Different technology platforms make it

More information

Catalent Biologics & Clinical Supplies The SMART Solution

Catalent Biologics & Clinical Supplies The SMART Solution Catalent Biologics & Clinical Supplies The SMART Solution Advanced Technology and Integrated Solutions From DNA to Clinical Supply & Cold Chain Distribution Dr. Florian Schwaak Account Manager Germany

More information

Quality and Safety Evaluation of Gene Therapy Products in Japan

Quality and Safety Evaluation of Gene Therapy Products in Japan Quality and Safety Evaluation of Gene Therapy Products in Japan Review Mechanism for Gene Therapy in Japan The review mechanism for gene therapy in Japan was partially amended to simplify the necessary

More information

Monoclonal Antibody Production: Building the Platform. Andrew Clutterbuck Eden Biodesign Ltd.

Monoclonal Antibody Production: Building the Platform. Andrew Clutterbuck Eden Biodesign Ltd. Monoclonal Antibody Production: Building the Platform Andrew Clutterbuck Eden Biodesign Ltd. Questions Questions are encouraged throughout the presentation and can be asked by using the email address provided

More information

Integrated Protein Services

Integrated Protein Services Integrated Protein Services Custom protein expression & purification Last date of revision June 2015 Version DC04-0013 www.iba-lifesciences.com Expression strategy The first step in the recombinant protein

More information

Transgenic technology in the production of therapeutic proteins

Transgenic technology in the production of therapeutic proteins Transgenic technology in the production of therapeutic proteins Transgenic technology represents a new generation of biopharmaceutical production system to meet the medical needs of the new millennium.

More information

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE Q5B

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE Q5B INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE QUALITY OF BIOTECHNOLOGICAL PRODUCTS: ANALYSIS

More information

Setting the Standard for Plasmid DNA Production

Setting the Standard for Plasmid DNA Production Setting the Standard for Plasmid DNA Production Dr. Wolfgang Buchinger Boehringer Ingelheim RCV GmbH & Co. KG Contact: bioxcellence@boehringer-ingelheim.com Gene Vaccination and Gene Therapy Nucleic acid

More information

Dr.ssa Maria Luisa Nolli CEO

Dr.ssa Maria Luisa Nolli CEO IL RUOLO DELLE PICCOLE E MEDIE INDUSTRIE NELLA PROMOZIONE DELLA MEDICINA TRASLAZIONALE Quality and Innovation Dr.ssa Maria Luisa Nolli CEO INTRODUCTION ARETA INTERNATIONAL 12 years of experience in contract

More information

Catching the Flu: A Photo Essay

Catching the Flu: A Photo Essay May 2006 Catching the Flu: A Photo Essay As it tests a new way of making vaccines, TechnoVax is targeting the deadly 1918 flu virus. By Stephan Herrera (MIT Technology Review) Jose Galarza is the CEO of

More information

High yield antibody production in a disposable WAVE Bioreactor

High yield antibody production in a disposable WAVE Bioreactor High yield antibody production in a Process intensification using perfusion culture Christian Kaisermayer 1, Jianjun Yang 2 1 GE Healthcare Europe GmbH, Vienna, Austria (Christian.Kaisermayer@ge.com),

More information

Vaccine Production Strategies: Ensuring Alignment and Sustainability

Vaccine Production Strategies: Ensuring Alignment and Sustainability Vaccine Production Strategies: Ensuring Alignment and Sustainability Second WHO Consultation on Global Action Plan for Influenza Vaccines (GAP-II) Robert W Malone, MD, MS Consulting, Vaccines and Biologicals

More information

European Medicines Agency

European Medicines Agency European Medicines Agency July 1996 CPMP/ICH/139/95 ICH Topic Q 5 B Quality of Biotechnological Products: Analysis of the Expression Construct in Cell Lines Used for Production of r-dna Derived Protein

More information

Name Date Per. CH 15: GENETIC ENGINEERING STUDY QUESTIONS (pages )

Name Date Per. CH 15: GENETIC ENGINEERING STUDY QUESTIONS (pages ) WLHS / Biology / Oppelt Name Date Per CH 15: GENETIC ENGINEERING STUDY QUESTIONS (pages 416-433) 15.1: Selective Breeding 1) Define the following terms: Selective Breeding: Hybridization: Inbreeding: 2)

More information

Use of the ambr 250 in combination with high-throughput design and analysis tools for rapid, scalable USP development

Use of the ambr 250 in combination with high-throughput design and analysis tools for rapid, scalable USP development Use of the ambr 250 in combination with high-throughput design and analysis tools for rapid, scalable USP development Authors: Dr Fern Slingsby and Dr Simon Dewar Upstream Process Development FUJIFILM

More information

Table of Contents. Presented by

Table of Contents. Presented by Improving Markets, Services, and Technologies Table of Contents Presented by HighTech Business Decisions 3150 Almaden Expressway, Suite 222, San Jose, CA 95118 Tel: (408) 978-1035 Fax: (408) 978-8925 www.hightechdecisions.com

More information

Facility construction and start up for commercial scale manufacturing of monoclonal antibodies - A case study

Facility construction and start up for commercial scale manufacturing of monoclonal antibodies - A case study 24 th Interphex, Japan, Technical Conference June 29 th, 2011 Michael Brown Facility construction and start up for commercial scale manufacturing of monoclonal antibodies - A case study Lonza AG Financially

More information

Cell Culture Influenza Vaccines: The current status

Cell Culture Influenza Vaccines: The current status Cell Culture Influenza Vaccines: The current status Han van den Bosch, Amsterdam, The Netherlands 7th WHO Meeting on Influenza Vaccine Technology Transfer to Developing Country Manufacturers. Dubai, 25-26

More information

Triskel: a strategic consulting firm for biopharmaceutical companies

Triskel: a strategic consulting firm for biopharmaceutical companies BioStart : Manufacturing and operations in Biotech Strategic stakes and technology evolution in recombinant protein production APFL May 14 th, 2009 François LAWNY Triskel Integrated Services Geneva, Switzerland

More information

The Leading Gene Through Screen CRO

The Leading Gene Through Screen CRO The Leading Gene Through Screen CRO Molecular Biology Services Molecular Biology drives modern drug discovery. Drug screening, target validation and structural biology processes frequently require recombinant

More information

BIOTECHNOLOGY OPERATIONS

BIOTECHNOLOGY OPERATIONS BIOTECHNOLOGY OPERATIONS Principles and Practices Michael J. Roy TECHNISCHE INFORMATION SBIBLIOTHEK UNIVERSITATSBIBLIOTHEK HANNOVER CRC Press TaylorStFrancis Croup Boca Raton London New York CRC Press

More information

Guideline on process validation for the manufacture of biotechnology-derived active substances and data to be provided in the regulatory submission

Guideline on process validation for the manufacture of biotechnology-derived active substances and data to be provided in the regulatory submission 28 April 2016 EMA/CHMP/BWP/187338/2014 Committee for Medicinal Products for Human Use (CHMP) Guideline on process validation for the manufacture of biotechnology-derived active substances and data to be

More information

Challenges in the cgmp Manufacturing of hescs: Lessons Learned from Monoclonal Antibodies

Challenges in the cgmp Manufacturing of hescs: Lessons Learned from Monoclonal Antibodies Challenges in the cgmp Manufacturing of hescs: Lessons Learned from Monoclonal Antibodies ISCT 2011 Annual Meeting Rotterdam, The Netherlands May 18 21, 2011 BioProcess Technology Consultants www.bptc.com

More information

Guideline on process validation for the manufacture of biotechnology-derived active substances and data to be provided in the regulatory submission

Guideline on process validation for the manufacture of biotechnology-derived active substances and data to be provided in the regulatory submission 1 2 3 25 April 2014 Committee for Medicinal Products for Human Use (CHMP) 4 5 6 7 Guideline on process validation for the manufacture of biotechnology-derived active substances and data to be provided

More information

Production of antigens and antibodies in plants: alternative technology?

Production of antigens and antibodies in plants: alternative technology? Production of antigens and antibodies in plants: alternative technology? George Lomonossoff John Innes Centre Norwich, UK ECOPA, Alicante 29 th Sept. 2006 Why use Plants as Biofactories? Produce large

More information

BaculoDirect Baculovirus Expression System Free your hands with the BaculoDirect Baculovirus Expression System

BaculoDirect Baculovirus Expression System Free your hands with the BaculoDirect Baculovirus Expression System BaculoDirect Baculovirus Expression System Free your hands with the BaculoDirect Baculovirus Expression System The BaculoDirect Baculovirus Expression System gives you: Unique speed and simplicity High-throughput

More information

Introduction to Bioprocessing

Introduction to Bioprocessing Introduction to Bioprocessing Cambridge Healthtech Institute Peptalk Palm Springs, CA Presented by Susan Dana Jones and Sheila Magil BioProcess Technology Consultants www.bptc.com BioProcess Technology

More information

Products For Cell Line Development

Products For Cell Line Development Products For Cell Line Development Table of Contents 3 ClonaCell Products for Cell Line Development 4 Semi-Solid Cloning for Cell Line Development 5 Semi-Solid Cloning Delivers a High Probability of Monoclonality

More information

A World of Biomanufacturing: Shortages or Global Glut?

A World of Biomanufacturing: Shortages or Global Glut? A World of Biomanufacturing: Shortages or Global Glut? Howard L. Levine, Ph.D. BioProcess Technology Consultants, Inc. BioProcess International Conference Vienna, Austria May 19-20, 2010 Steady growth

More information

Overview of Phase 1 Oncology Trials of Biologic Therapeutics

Overview of Phase 1 Oncology Trials of Biologic Therapeutics Overview of Phase 1 Oncology Trials of Biologic Therapeutics Susan Jerian, MD ONCORD, Inc. February 28, 2008 February 28, 2008 Phase 1 1 Assumptions and Ground Rules The goal is regulatory approval of

More information

EMABling Antibody Production Platform

EMABling Antibody Production Platform EMABling Antibody Production Platform An industrial solution for the production of therapeutic antibodies with high cytotoxic activity B IOMANUFACTURING EMABling : A fully integrated development platform

More information

Introduction to Activity 3. Biotechnology and Human Health

Introduction to Activity 3. Biotechnology and Human Health Introduction to Activity 3 Biotechnology and Human Health Biotechnology and You Background Biotechnology is used to: Diagnose disease Prevent disease Treat disease How can biotechnology diagnose disease?

More information

Host cell Protein Clearance and Detection: Critical issues for Biopharmaceutical development

Host cell Protein Clearance and Detection: Critical issues for Biopharmaceutical development Host cell Protein Clearance and Detection: Critical issues for Biopharmaceutical development Protein Quantification workshop, Waters: 13 th November 2012 Vincent Monchois, R&D and Pilot Services Manager,

More information

Name: Period: Date: Biotechnology refers to technology used to DNA. The procedures are often referred to as. DNA is cut into small pieces using (RE).

Name: Period: Date: Biotechnology refers to technology used to DNA. The procedures are often referred to as. DNA is cut into small pieces using (RE). Name: Period: Date: I. OVERVIEW OF GENETIC ENGINEERING: Biotechnology refers to technology used to DNA. The procedures are often referred to as. is the genetic material of all living organisms. o All organisms

More information

THE DEVELOPMENT OF THERAPEUTIC MONOCLONAL ANTIBODY PRODUCTS

THE DEVELOPMENT OF THERAPEUTIC MONOCLONAL ANTIBODY PRODUCTS THE DEVELOPMENT OF THERAPEUTIC MONOCLONAL ANTIBODY PRODUCTS Table of Contents CHAPTER 1: Overview of Monoclonal Antibody Therapeutics CHAPTER 2: Monoclonal Antibody Discovery Technologies CHAPTER 3: CMC

More information

PX Therapeutics : the partner for early stage biotherapeutics development Biotuesday, May 5 2009

PX Therapeutics : the partner for early stage biotherapeutics development Biotuesday, May 5 2009 PX Therapeutics : the partner for early stage biotherapeutics development Biotuesday, May 5 2009 Christelle Dagoneau, PhD Business Development Director Company Profile Protein expert incorporated in 2000

More information

Expectations for Data to Support Clinical Trial Drugs

Expectations for Data to Support Clinical Trial Drugs Expectations for Data to Support Clinical Trial Drugs Presentation to: APEC Advanced Workshop on Review of Drug Development in Clinical Trials Bangkok Thailand Feb 2-6 2009 Willem Stevens Ph.D., Chief

More information

Microbiology / Active Lecture Questions Chapter 9 Biotechnology & Recombinant DNA 1 Chapter 9 Biotechnology & Recombinant DNA

Microbiology / Active Lecture Questions Chapter 9 Biotechnology & Recombinant DNA 1 Chapter 9 Biotechnology & Recombinant DNA 1 2 Restriction enzymes were first discovered with the observation that a. DNA is restricted to the nucleus. b. phage DNA is destroyed in a host cell. c. foreign DNA is kept out of a cell. d. foreign DNA

More information

Workshop on process validation

Workshop on process validation Workshop on process validation CMC Strategy Forum Europe 2013 EBE Process validation satellite session Pragues, 06/05/2013 Kowid Ho Scope / background Process evaluation/validation of biotechnology derived

More information

TransIT -2020 Transfection Reagent

TransIT -2020 Transfection Reagent Quick Reference Protocol, MSDS and Certificate of Analysis available at mirusbio.com/5400 INTRODUCTION TransIT -2020 Transfection Reagent is a high-performance, animal-origin free, broad spectrum reagent

More information

BIOTECH MANUFACTURING SOLUTIONS 4 YOUR SUCCESS. a Novartis company

BIOTECH MANUFACTURING SOLUTIONS 4 YOUR SUCCESS. a Novartis company a Novartis company BIOTECH MANUFACTURING Sandoz GmbH Biotech Cooperations 6250 Kundl Austria Biochemiestrasse10 Phone +43 (0)5338 200 2609 Fax +43 (0)5338 200 442 biotech.cooperations@sandoz.com www.sandoz.com

More information

CHAPTER 6: RECOMBINANT DNA TECHNOLOGY YEAR III PHARM.D DR. V. CHITRA

CHAPTER 6: RECOMBINANT DNA TECHNOLOGY YEAR III PHARM.D DR. V. CHITRA CHAPTER 6: RECOMBINANT DNA TECHNOLOGY YEAR III PHARM.D DR. V. CHITRA INTRODUCTION DNA : DNA is deoxyribose nucleic acid. It is made up of a base consisting of sugar, phosphate and one nitrogen base.the

More information

Plasmid Isolation. Prepared by Latifa Aljebali Office: Building 5, 3 rd floor, 5T250

Plasmid Isolation. Prepared by Latifa Aljebali Office: Building 5, 3 rd floor, 5T250 Plasmid Isolation Prepared by Latifa Aljebali Office: Building 5, 3 rd floor, 5T250 Plasmid Plasmids are small, double strand, closed circular DNA molecules. Isolated from bacterial cells. Replicate independently

More information

CHMP/BWP DRAFT GUIDELINE ON VIRUS SAFETY EVALUATION OF BIOTECHNOLOGICAL INVESTIGATIONAL MEDICINAL PRODUCTS

CHMP/BWP DRAFT GUIDELINE ON VIRUS SAFETY EVALUATION OF BIOTECHNOLOGICAL INVESTIGATIONAL MEDICINAL PRODUCTS European Medicines Agency Evaluation of Medicines for Human Use London, 28 June 2006 Doc. Ref. EMEA/CHMP/BWP/398498/2005-corr CHMP/BWP DRAFT GUIDELINE ON VIRUS SAFETY EVALUATION OF BIOTECHNOLOGICAL INVESTIGATIONAL

More information

Biotechpharma company profile

Biotechpharma company profile Biotechpharma company profile October 2013 1 History 2004 Biotechpharma UAB established as a proteomic research company in Vilnius, Lithuania 2005 Company became a member of UK s Northway group, investing

More information

Economical Approaches to Meeting Global Demand for High Value Biopharmaceuticals

Economical Approaches to Meeting Global Demand for High Value Biopharmaceuticals Economical Approaches to Meeting Global Demand for High Value Biopharmaceuticals Howard L. Levine and Susan Dana Jones BPI Europe 2013 Apr 17-18, 2013 Dusseldorf, Germany BioProcess Technology Consultants

More information

Biotechnology in Medicine and Agriculture

Biotechnology in Medicine and Agriculture Biotechnology in Medicine and Agriculture Bởi: OpenStaxCollege It is easy to see how biotechnology can be used for medicinal purposes. Knowledge of the genetic makeup of our species, the genetic basis

More information

Genetic Engineering and Biotechnology

Genetic Engineering and Biotechnology 1 So, what is biotechnology?? The use of living organisms to carry out defined chemical processes for industrial or commercial application. The office of Technology Assessment of the U.S. Congress defines

More information

WHITE PAPER: Rapid Quantification Of Egg-Grown Influenza

WHITE PAPER: Rapid Quantification Of Egg-Grown Influenza WHITE PAPER: Rapid Quantification Of Egg-Grown Influenza Introduction Embryonated chicken eggs have been the primary means of producing influenza vaccines for many decades. Although there has been significant

More information

Technology Transfer of CMC Activities for MAb Manufacturing. 2010 ge healthcare (www.gelifesciences.com)

Technology Transfer of CMC Activities for MAb Manufacturing. 2010 ge healthcare (www.gelifesciences.com) M a n u f a c t u r i n g OPERATIONS Technology Transfer of CMC Activities for MAb Manufacturing by Patricia Seymour, Susan Dana Jones, Howard L. Levine With combined 2009 revenues estimated to be over

More information

HSA Consumer Guide. Understanding Vaccines, Vaccine Development and Production. www.hsa.gov.sg November 2009. How a Vaccine Works.

HSA Consumer Guide. Understanding Vaccines, Vaccine Development and Production. www.hsa.gov.sg November 2009. How a Vaccine Works. November 2009 Understanding Vaccines, Vaccine Development and Production Vaccines, in general, help protect people from harmful infections before they come in contact with the disease. Vaccines may also

More information

Providing Trusted and Innovative Solutions t o the Life Science Communities

Providing Trusted and Innovative Solutions t o the Life Science Communities Providing Trusted and Innovative Solutions t o the Life Science Communities Eurogentec Eurogentec is a leading supplier of trusted and innovative reagents, kits, specialty products and custom research/development

More information

Genes to Proteins to Antibodies

Genes to Proteins to Antibodies Genes to Proteins to Antibodies About Us Fusion Antibodies is a CRO established in 2001 as a spin-out from Queen s University Belfast. The company building is situated in a charming area of Springbank

More information

Una nueva plataforma para la producción de vectores lentivirales para preclínica y bajo cgmp

Una nueva plataforma para la producción de vectores lentivirales para preclínica y bajo cgmp Una nueva plataforma para la producción de vectores lentivirales para preclínica y bajo cgmp XLVIII LECCIÓN CONMEMORATIVA JIMÉNEZ DÍAZ Madrid Mayo 2016 Juan C Ramírez CSO/CTO Non-Disclosure/Confidentiality

More information

From cells to therapeuticsvivalis. Humalex Fully human antibody discovery platform An integrated therapeutic development offering

From cells to therapeuticsvivalis. Humalex Fully human antibody discovery platform An integrated therapeutic development offering From cells to therapeuticsvivalis Humalex Fully human antibody discovery platform An integrated therapeutic development offering Humalex from bench-top to clinical development The Humalex platform enables

More information

the science of baculovirus expression

the science of baculovirus expression the science of baculovirus expression Oxford Expression Technologies (OET) is a biotechnology company and centre of excellence for baculovirus protein expression. Specialising in the use of the baculovirus

More information

PRODUCTION AND QUALITY CONTROL OF MEDICINAL PRODUCTS DERIVED BY RECOMBINANT DNA TECHNOLOGY

PRODUCTION AND QUALITY CONTROL OF MEDICINAL PRODUCTS DERIVED BY RECOMBINANT DNA TECHNOLOGY PRODUCTION AND QUALITY CONTROL OF MEDICINAL PRODUCTS DERIVED BY RECOMBINANT DNA TECHNOLOGY Guideline Title Production and Quality Control of Medicinal Products derived by recombinant DNA Technology Legislative

More information

Lonza Custom Manufacturing

Lonza Custom Manufacturing Lonza Custom Manufacturing Overview Lonza established the concept of custom manufacturing over 25 years ago, recognizing the trend toward outsourcing in the pharmaceutical industry. Since then, Lonza Custom

More information

A customizable ADCC assay service for antibodies & fusion proteins.

A customizable ADCC assay service for antibodies & fusion proteins. Antibody Dependent Cell- Mediated Cytotoxicity (ADCC) Assay A customizable ADCC assay service for antibodies & fusion proteins. Our ADCC assay service accurately detects cell lysis based on LDH-release.

More information

Protein Synthesis and Purification: Microbial Versus Mammalian Systems

Protein Synthesis and Purification: Microbial Versus Mammalian Systems STREAMLINING RECOMBINANT PROTEIN PRODUCTION The pharmaceutical industry is undergoing a deep transformation from small molecule drugs to biologics. Over the last decade, the percentage share of biologic-based

More information

"Small and large molecules bioproduction by mammalian and microbial fermentation"

Small and large molecules bioproduction by mammalian and microbial fermentation "Small and large molecules bioproduction by mammalian and microbial fermentation" H.-P. Meyer Bio/PharMOS 2004-23-25 March 2004 Symposium B Business Diversification in Life Science "Small and large molecules

More information

DEVELOPMENT AND MANUFACTURE OF DRUG SUBSTANCES (CHEMICAL ENTITIES AND BIOTECHNOLOGICAL/BIOLOGICAL ENTITIES) Q11

DEVELOPMENT AND MANUFACTURE OF DRUG SUBSTANCES (CHEMICAL ENTITIES AND BIOTECHNOLOGICAL/BIOLOGICAL ENTITIES) Q11 INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE DEVELOPMENT AND MANUFACTURE OF DRUG SUBSTANCES

More information

Recombinant DNA Technology

Recombinant DNA Technology PowerPoint Lecture Presentations prepared by Mindy Miller-Kittrell, North Carolina State University C H A P T E R 8 Recombinant DNA Technology The Role of Recombinant DNA Technology in Biotechnology Biotechnology

More information

Biosafety of Recombinant Viral Agents

Biosafety of Recombinant Viral Agents Biosafety of Recombinant Viral Agents Viral Vectors for Gene Therapy Introduction Biosafety Principles Biosafety Risk Categories Biosafety Risk Assessment Viral Vectors for Gene Therapy Classes of Viral

More information

Guidance for Industry. Monoclonal Antibodies Used as Reagents in Drug Manufacturing

Guidance for Industry. Monoclonal Antibodies Used as Reagents in Drug Manufacturing Guidance for Industry Monoclonal Antibodies Used as Reagents in Drug Manufacturing U.S. Department of Health and Human Services Food and Drug Administration enter for Drug Evaluation and Research (DER)

More information

Manufacturing Cellular Products for International Clinical Trials

Manufacturing Cellular Products for International Clinical Trials Manufacturing Cellular Products for International Clinical Trials Q U A L I T Y A N D O P E R A T I O N S T R A C K 7 4 / 2 5 / 1 4 1 3 : 4 5-1 5 : 1 5 Olive J Sturtevant, MHP,MT (ASCP)SBB, CQA Director

More information

The correct answer is c B. Answer b is incorrect. Type II enzymes recognize and cut a specific site, not at random sites.

The correct answer is c B. Answer b is incorrect. Type II enzymes recognize and cut a specific site, not at random sites. 1. A recombinant DNA molecules is one that is a. produced through the process of crossing over that occurs in meiosis b. constructed from DNA from different sources c. constructed from novel combinations

More information

Roles of Plant Tissue Culture in Plant Genetic Engineering

Roles of Plant Tissue Culture in Plant Genetic Engineering Roles of Plant Tissue Culture in Plant Genetic Engineering What are Transgenic Plants? Plants that contain a source gene inserted from a species outside of the target plant species. The gene may 1) have

More information

ICH guideline Q11 on development and manufacture of drug substances (chemical entities and biotechnological/biological entities)

ICH guideline Q11 on development and manufacture of drug substances (chemical entities and biotechnological/biological entities) May 2011 EMA/CHMP/ICH/425213/2011 ICH/ Committee for medicinal products for human use (CHMP) ICH guideline Q11 on development and manufacture of drug substances (chemical entities and biotechnological/biological

More information

Annex 5: Vaccination Development and Production - Draft Table of Contents

Annex 5: Vaccination Development and Production - Draft Table of Contents Table of Contents I. Introduction to Vaccine Development and Production.2 II. Background and Current Status. 2 A. Use of Chicken Eggs.....3 B. Composition of Annual Influenza Vaccine... 3 C. Vaccine doses.....

More information

USE OF TRANSGENIC ANIMALS IN THE MANUFACTURE OF BIOLOGICAL MEDICINAL PRODUCTS FOR HUMAN USE

USE OF TRANSGENIC ANIMALS IN THE MANUFACTURE OF BIOLOGICAL MEDICINAL PRODUCTS FOR HUMAN USE USE OF TRANSGENIC ANIMALS IN THE MANUFACTURE OF BIOLOGICAL MEDICINAL PRODUCTS FOR HUMAN USE Guideline Title Use Of Transgenic Animals In The Manufacture Of Biological Medicinal Products For Human Use Legislative

More information

Clinical Trials in Thalassemia Cell and Gene Therapy Grant Award

Clinical Trials in Thalassemia Cell and Gene Therapy Grant Award Clinical Trials in Thalassemia Cell and Gene Therapy Grant Award The Cooley s Anemia Foundation invites national and international applicants to apply for grants to facilitate clinical trials in Cell and

More information

KMS-Specialist & Customized Biosimilar Service

KMS-Specialist & Customized Biosimilar Service KMS-Specialist & Customized Biosimilar Service 1. Polyclonal Antibody Development Service KMS offering a variety of Polyclonal Antibody Services to fit your research and production needs. we develop polyclonal

More information

DNA TECHNOLOGY- methods for studying and manipulating genetic material.

DNA TECHNOLOGY- methods for studying and manipulating genetic material. 1 DNA TECHNOLOGY- methods for studying and manipulating genetic material. BIOTECHNOLOGY, the manipulation of organisms or their components to make useful products. Biotechnology today usually refers to

More information

ANTIBODY AND CYTOKINE DEVELOPMENTS AND SERVICES. Zsolt Keresztessy, PhD MBA TUDOMÁNYOS HÉTFŐ 2012.04.23.

ANTIBODY AND CYTOKINE DEVELOPMENTS AND SERVICES. Zsolt Keresztessy, PhD MBA TUDOMÁNYOS HÉTFŐ 2012.04.23. ANTIBODY AND CYTOKINE DEVELOPMENTS AND SERVICES AT DEBRECEN CLINICAL GENOMICS CENTER DEPT BIOCHEMISTRY AND MOLECULAR BIOLOGY Zsolt Keresztessy, PhD MBA TUDOMÁNYOS HÉTFŐ 2012.04.23. MISSION CUTTING EDGE

More information

Overview of Upstream and Downstream Processing of Biopharmaceuticals

Overview of Upstream and Downstream Processing of Biopharmaceuticals Overview of Upstream and Downstream Processing of Biopharmaceuticals Ian Marison Professor of Bioprocess Engineering and Head of School of Biotechnology, Dublin City University, Glasnevin, Dublin 9, Ireland

More information

STANDARD 2 Students will demonstrate appropriate safety procedures and equipment use in the laboratory.

STANDARD 2 Students will demonstrate appropriate safety procedures and equipment use in the laboratory. BIOTECHNOLOGY Levels: 11-12 Units of Credit: 1.0 CIP Code: 51.1201 Prerequisite: Biology or Chemistry Skill Certificates: #708 COURSE DESCRIPTION is an exploratory course designed to create an awareness

More information